Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Medtronic
McKesson
Harvard Business School
Dow

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Patent: 6,093,398

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 6,093,398
Title: Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
Abstract:The use of an MMP inhibitor, especially a collagenase inhibitor, in the manufacture of a medicament for the treatment of a natural or artificial tissue comprising extracellular matrix components to inhibit contraction of the tissue and methods for the treatment of tissue comprising extracellular matrix components to inhibit contraction.
Inventor(s): Khaw; Peng Tee (London, GB), Schultz; Gregory S. (Gainesville, FL)
Assignee: University of Florida Research Found (Gainesville, FL) Institute of Ophthalmology (London, GB) Moorfields Eye Hospital NHS Trust (London, GB)
Application Number:08/716,155
Patent Claims:see list of patent claims

Details for Patent 6,093,398

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial University of Florida Research Found (Gainesville, FL) Institute of Ophthalmology (London, GB) Moorfields Eye Hospital NHS Trust (London, GB) 2014-03-16 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 6,093,398

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 9524921 Sep 21, 1995
United States of America 2002164319 Nov 07, 2002
United States of America 6379667 Apr 30, 2002
United States of America 6759432 Jul 06, 2004
United Kingdom 9405076 Apr 27, 1994
European Patent Office 0750512 Jan 02, 1997
European Patent Office 0750512 Jul 13, 2005
>Country >Patent Number >Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Harvard Business School
AstraZeneca
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.